LIGAND PHARMACEUTICALS INCORPORATED Tenant Reimbursements (Deprecated 2018-01-31)
LIGAND PHARMACEUTICALS INCORPORATED (LGNDZ) reported Tenant Reimbursements (Deprecated 2018-01-31) of $3.20 million for the 12-month period ending 2014-12-31, per its 10-K filed 2015-02-23.
Discontinued › Notes
us-gaap:TenantReimbursements · last filed 2015-02-23
- LIGAND PHARMACEUTICALS INCORPORATED tenant reimbursements (deprecated 2018-01-31) for the quarter ending 2013-12-31 was $0.00.
- LIGAND PHARMACEUTICALS INCORPORATED tenant reimbursements (deprecated 2018-01-31) for the quarter ending 2013-09-30 was $0.00.
- LIGAND PHARMACEUTICALS INCORPORATED tenant reimbursements (deprecated 2018-01-31) for the quarter ending 2013-06-30 was $0.00.
- LIGAND PHARMACEUTICALS INCORPORATED tenant reimbursements (deprecated 2018-01-31) for the quarter ending 2013-03-31 was $3.20M.
- LIGAND PHARMACEUTICALS INCORPORATED tenant reimbursements (deprecated 2018-01-31) for fiscal 2014 was $3.20M, a 0.00% change from fiscal 2013.
- LIGAND PHARMACEUTICALS INCORPORATED tenant reimbursements (deprecated 2018-01-31) for fiscal 2013 was $3.20M.
- LIGAND PHARMACEUTICALS INCORPORATED tenant reimbursements (deprecated 2018-01-31) for fiscal 2012 was -$3.20M.
| Period end | Tenant Reimbursements (Deprecated 2018-01-31) 3 month | Tenant Reimbursements (Deprecated 2018-01-31) 6 month | Tenant Reimbursements (Deprecated 2018-01-31) 9 month | Tenant Reimbursements (Deprecated 2018-01-31) 12 month |
|---|---|---|---|---|
| 2014-12-31 | $3.20M 10-K · filed 2015-02-23 | |||
| 2013-12-31 | $0.00 derived: 10-K/A 12 month − 10-Q 9 month · filed 2014-12-12 | $0.00 derived: sum of 2 quarters · filed 2014-12-12 | $0.00 derived: sum of 3 quarters · filed 2014-12-12 | $3.20M 10-K/A · filed 2014-12-12 |
| 2013-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-08 | $0.00 derived: sum of 2 quarters · filed 2013-11-08 | $3.20M 10-Q · filed 2013-11-08 | |
| 2013-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-01 | $3.20M 10-Q · filed 2013-08-01 | ||
| 2013-03-31 | $3.20M 10-Q · filed 2013-05-08 | |||
| 2012-12-31 | -$3.20M 10-K · filed 2013-03-14 |